FDA chief's visit may soothe jittery nerves

At a time when leading Indian pharmaceutical companies have been cited for infringements by the US drug regulator, its chief Margaret Hamburg is planning her first visit to India, most likely later this year or early next year. Originally scheduled for October, the trip by the US Food and Drug Administration commissioner had to be postponed at the last moment because of the US "partial government shut down", a USFDA spokesperson confirmed to ET.

Read Full Story>>